Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Indians, North American | 15 | 2024 | 354 | 3.660 |
Why?
|
Tuberculosis, Multidrug-Resistant | 40 | 2025 | 941 | 3.370 |
Why?
|
Antitubercular Agents | 38 | 2025 | 1380 | 2.820 |
Why?
|
Directly Observed Therapy | 11 | 2018 | 139 | 2.400 |
Why?
|
Peru | 46 | 2025 | 888 | 2.310 |
Why?
|
Community-Institutional Relations | 7 | 2020 | 209 | 2.220 |
Why?
|
Tuberculosis | 20 | 2016 | 2010 | 1.890 |
Why?
|
Antiretroviral Therapy, Highly Active | 9 | 2019 | 1899 | 1.640 |
Why?
|
Community Health Services | 8 | 2020 | 657 | 1.350 |
Why?
|
HIV Infections | 24 | 2023 | 17535 | 1.270 |
Why?
|
Fruit | 3 | 2021 | 1167 | 1.090 |
Why?
|
Vegetables | 3 | 2021 | 1200 | 1.090 |
Why?
|
Program Evaluation | 8 | 2020 | 2502 | 1.020 |
Why?
|
Alcoholism | 7 | 2016 | 1979 | 1.000 |
Why?
|
Mycobacterium tuberculosis | 18 | 2016 | 1910 | 0.900 |
Why?
|
Naltrexone | 4 | 2013 | 319 | 0.860 |
Why?
|
Community-Based Participatory Research | 2 | 2024 | 223 | 0.850 |
Why?
|
Russia | 13 | 2016 | 383 | 0.830 |
Why?
|
Tuberculosis, Pulmonary | 14 | 2016 | 836 | 0.800 |
Why?
|
Social Support | 10 | 2022 | 2190 | 0.790 |
Why?
|
Diabetes Mellitus | 5 | 2020 | 5889 | 0.750 |
Why?
|
Food Supply | 5 | 2022 | 544 | 0.740 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 3 | 2010 | 85 | 0.690 |
Why?
|
Health Services, Indigenous | 2 | 2018 | 47 | 0.680 |
Why?
|
Drug Resistance, Multiple, Bacterial | 9 | 2014 | 592 | 0.680 |
Why?
|
Nutritional Requirements | 1 | 2021 | 276 | 0.670 |
Why?
|
Poverty | 10 | 2023 | 2714 | 0.670 |
Why?
|
New Mexico | 5 | 2020 | 80 | 0.630 |
Why?
|
Nutritive Value | 1 | 2021 | 350 | 0.610 |
Why?
|
Health Promotion | 4 | 2024 | 2209 | 0.550 |
Why?
|
Pregnancy in Diabetics | 1 | 2018 | 198 | 0.540 |
Why?
|
Patient Participation | 4 | 2020 | 1447 | 0.540 |
Why?
|
Parenting | 2 | 2025 | 708 | 0.520 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2019 | 949 | 0.510 |
Why?
|
Arizona | 3 | 2020 | 108 | 0.490 |
Why?
|
Utah | 3 | 2020 | 130 | 0.490 |
Why?
|
Patient Acceptance of Health Care | 2 | 2020 | 3230 | 0.490 |
Why?
|
Financial Management | 2 | 2022 | 161 | 0.480 |
Why?
|
Rifampin | 3 | 2025 | 350 | 0.480 |
Why?
|
Southwestern United States | 3 | 2020 | 39 | 0.470 |
Why?
|
Antibiotics, Antitubercular | 3 | 2005 | 100 | 0.460 |
Why?
|
Health Education | 2 | 2025 | 1060 | 0.460 |
Why?
|
Professional Role | 1 | 2017 | 314 | 0.450 |
Why?
|
Urban Population | 4 | 2011 | 2040 | 0.450 |
Why?
|
United States Indian Health Service | 2 | 2024 | 31 | 0.440 |
Why?
|
Alcohol Deterrents | 1 | 2013 | 49 | 0.420 |
Why?
|
Child Development | 3 | 2025 | 2327 | 0.420 |
Why?
|
Needs Assessment | 3 | 2016 | 1140 | 0.420 |
Why?
|
Clinical Laboratory Information Systems | 5 | 2014 | 108 | 0.400 |
Why?
|
Laboratories | 5 | 2014 | 463 | 0.380 |
Why?
|
Microbial Sensitivity Tests | 12 | 2016 | 1971 | 0.380 |
Why?
|
Viral Load | 3 | 2023 | 3386 | 0.380 |
Why?
|
Medication Adherence | 4 | 2022 | 2190 | 0.380 |
Why?
|
Residence Characteristics | 4 | 2018 | 2116 | 0.380 |
Why?
|
AIDS-Related Opportunistic Infections | 4 | 2012 | 663 | 0.370 |
Why?
|
Social Stigma | 2 | 2014 | 787 | 0.350 |
Why?
|
Humans | 116 | 2025 | 766117 | 0.340 |
Why?
|
Qualitative Research | 8 | 2022 | 3138 | 0.340 |
Why?
|
Anti-HIV Agents | 4 | 2023 | 4561 | 0.340 |
Why?
|
Adult | 55 | 2025 | 223139 | 0.340 |
Why?
|
Behavior Therapy | 2 | 2013 | 886 | 0.330 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2009 | 2184 | 0.330 |
Why?
|
Female | 71 | 2025 | 396233 | 0.320 |
Why?
|
Male | 66 | 2025 | 363935 | 0.320 |
Why?
|
Social Justice | 1 | 2014 | 484 | 0.320 |
Why?
|
Patient Compliance | 6 | 2022 | 2694 | 0.310 |
Why?
|
Tuberculosis, Central Nervous System | 1 | 2008 | 16 | 0.310 |
Why?
|
Tuberculosis, Cutaneous | 1 | 2008 | 17 | 0.310 |
Why?
|
Verbal Behavior | 1 | 2008 | 328 | 0.280 |
Why?
|
Cause of Death | 1 | 2017 | 3715 | 0.280 |
Why?
|
Stereotyping | 1 | 2008 | 242 | 0.270 |
Why?
|
Health Personnel | 3 | 2020 | 3387 | 0.270 |
Why?
|
Patient Care Management | 1 | 2009 | 301 | 0.260 |
Why?
|
Treatment Outcome | 27 | 2025 | 65219 | 0.260 |
Why?
|
Counseling | 4 | 2019 | 1553 | 0.250 |
Why?
|
Middle Aged | 34 | 2024 | 223083 | 0.250 |
Why?
|
Career Choice | 1 | 2012 | 769 | 0.240 |
Why?
|
HIV | 2 | 2012 | 1587 | 0.240 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2020 | 12235 | 0.240 |
Why?
|
Health Status | 4 | 2023 | 4086 | 0.240 |
Why?
|
Psychometrics | 1 | 2014 | 3060 | 0.240 |
Why?
|
Rural Population | 4 | 2024 | 2318 | 0.230 |
Why?
|
Public Health | 2 | 2022 | 2681 | 0.230 |
Why?
|
Patient Readmission | 1 | 2018 | 3283 | 0.230 |
Why?
|
Interviews as Topic | 6 | 2020 | 2741 | 0.220 |
Why?
|
Language | 2 | 2014 | 1550 | 0.220 |
Why?
|
Cycloserine | 1 | 2004 | 118 | 0.220 |
Why?
|
Psychoses, Substance-Induced | 1 | 2004 | 98 | 0.220 |
Why?
|
Mental Health | 3 | 2022 | 3273 | 0.210 |
Why?
|
Prevalence | 8 | 2023 | 15827 | 0.210 |
Why?
|
Hypokalemia | 1 | 2004 | 152 | 0.210 |
Why?
|
HIV Seropositivity | 1 | 2008 | 961 | 0.200 |
Why?
|
Young Adult | 14 | 2023 | 59868 | 0.200 |
Why?
|
Drug Resistance, Multiple | 2 | 2003 | 255 | 0.200 |
Why?
|
Narcotic Antagonists | 3 | 2013 | 591 | 0.200 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2005 | 366 | 0.200 |
Why?
|
Prisoners | 1 | 2006 | 315 | 0.200 |
Why?
|
Nutrition Disorders | 1 | 2023 | 203 | 0.200 |
Why?
|
Drug Therapy, Combination | 9 | 2016 | 6309 | 0.200 |
Why?
|
Attitude of Health Personnel | 2 | 2017 | 3928 | 0.200 |
Why?
|
Primary Health Care | 2 | 2022 | 4736 | 0.200 |
Why?
|
Developing Countries | 8 | 2020 | 2914 | 0.200 |
Why?
|
Program Development | 4 | 2012 | 1297 | 0.190 |
Why?
|
Food | 2 | 2023 | 764 | 0.190 |
Why?
|
Taxes | 1 | 2023 | 219 | 0.180 |
Why?
|
Retrospective Studies | 26 | 2023 | 81565 | 0.180 |
Why?
|
Mother-Child Relations | 1 | 2025 | 498 | 0.180 |
Why?
|
Medically Underserved Area | 3 | 2012 | 267 | 0.180 |
Why?
|
Child, Preschool | 14 | 2025 | 42511 | 0.180 |
Why?
|
Focus Groups | 3 | 2022 | 1459 | 0.180 |
Why?
|
Adolescent | 24 | 2025 | 88819 | 0.180 |
Why?
|
Telephone | 1 | 2024 | 627 | 0.180 |
Why?
|
Sputum | 6 | 2016 | 513 | 0.180 |
Why?
|
Proportional Hazards Models | 8 | 2017 | 12529 | 0.170 |
Why?
|
Organizations, Nonprofit | 2 | 2020 | 105 | 0.170 |
Why?
|
Commerce | 2 | 2022 | 612 | 0.170 |
Why?
|
Beverages | 2 | 2023 | 819 | 0.160 |
Why?
|
Sex Distribution | 3 | 2011 | 2270 | 0.160 |
Why?
|
Brain Diseases | 1 | 2008 | 1552 | 0.160 |
Why?
|
Infant | 10 | 2025 | 36427 | 0.160 |
Why?
|
Mass Screening | 3 | 2011 | 5450 | 0.160 |
Why?
|
Trust | 2 | 2017 | 532 | 0.160 |
Why?
|
Methicillin Resistance | 1 | 1999 | 198 | 0.150 |
Why?
|
Physicians | 3 | 2013 | 4591 | 0.150 |
Why?
|
Caregivers | 2 | 2023 | 2304 | 0.150 |
Why?
|
Combined Modality Therapy | 5 | 2016 | 8525 | 0.150 |
Why?
|
Cohort Studies | 15 | 2023 | 41684 | 0.140 |
Why?
|
Prescriptions | 1 | 2020 | 388 | 0.140 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2003 | 713 | 0.140 |
Why?
|
Sexual Partners | 1 | 2022 | 804 | 0.140 |
Why?
|
Government Regulation | 1 | 2021 | 525 | 0.140 |
Why?
|
Alcohol-Related Disorders | 2 | 2010 | 243 | 0.140 |
Why?
|
Psychology | 2 | 2009 | 353 | 0.130 |
Why?
|
Child | 16 | 2025 | 80573 | 0.130 |
Why?
|
Pilot Projects | 3 | 2022 | 8724 | 0.130 |
Why?
|
Geography | 1 | 2018 | 651 | 0.130 |
Why?
|
Postnatal Care | 1 | 2018 | 273 | 0.130 |
Why?
|
Risk Factors | 13 | 2023 | 74857 | 0.130 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1666 | 0.130 |
Why?
|
United States | 12 | 2024 | 72920 | 0.120 |
Why?
|
Professional-Patient Relations | 2 | 2020 | 723 | 0.120 |
Why?
|
Aged | 13 | 2024 | 171219 | 0.120 |
Why?
|
Adaptation, Psychological | 2 | 2019 | 2662 | 0.120 |
Why?
|
Time Factors | 10 | 2018 | 40108 | 0.110 |
Why?
|
Case-Control Studies | 4 | 2022 | 22228 | 0.110 |
Why?
|
Practice Guidelines as Topic | 5 | 2024 | 7424 | 0.110 |
Why?
|
Alaska | 1 | 2014 | 68 | 0.110 |
Why?
|
Aged, 80 and over | 5 | 2020 | 59515 | 0.110 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1735 | 0.110 |
Why?
|
Appointments and Schedules | 1 | 2018 | 441 | 0.110 |
Why?
|
Health Services Needs and Demand | 2 | 2012 | 1404 | 0.110 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15647 | 0.110 |
Why?
|
Quality Assurance, Health Care | 3 | 2008 | 2171 | 0.110 |
Why?
|
Emotions | 2 | 2019 | 2758 | 0.110 |
Why?
|
Attitude to Health | 2 | 2020 | 2020 | 0.110 |
Why?
|
Guideline Adherence | 3 | 2024 | 2235 | 0.110 |
Why?
|
Mothers | 2 | 2025 | 2206 | 0.100 |
Why?
|
Prospective Studies | 6 | 2020 | 54812 | 0.100 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2005 | 2538 | 0.100 |
Why?
|
Sexual Behavior | 1 | 2022 | 2192 | 0.100 |
Why?
|
Statistics, Nonparametric | 1 | 2017 | 2844 | 0.100 |
Why?
|
Depressive Disorder | 1 | 2004 | 3712 | 0.090 |
Why?
|
Heart Failure | 3 | 2024 | 11837 | 0.090 |
Why?
|
Population Surveillance | 3 | 2011 | 2596 | 0.090 |
Why?
|
Multi-Institutional Systems | 1 | 2010 | 43 | 0.090 |
Why?
|
Logistic Models | 3 | 2018 | 13273 | 0.090 |
Why?
|
Patient Credit and Collection | 1 | 2010 | 16 | 0.090 |
Why?
|
Prenatal Care | 1 | 2018 | 1158 | 0.090 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26290 | 0.090 |
Why?
|
Anthropology, Cultural | 1 | 2010 | 103 | 0.090 |
Why?
|
Pregnancy | 5 | 2023 | 30233 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6506 | 0.080 |
Why?
|
Poverty Areas | 1 | 2011 | 268 | 0.080 |
Why?
|
Empathy | 1 | 2014 | 474 | 0.080 |
Why?
|
Tetrazolium Salts | 1 | 2009 | 92 | 0.080 |
Why?
|
Narration | 1 | 2012 | 223 | 0.080 |
Why?
|
Culture Media | 2 | 2009 | 889 | 0.080 |
Why?
|
Isoniazid | 1 | 2011 | 279 | 0.080 |
Why?
|
Mycobacterium avium Complex | 1 | 2009 | 66 | 0.080 |
Why?
|
Anxiety | 1 | 2004 | 4672 | 0.080 |
Why?
|
Clarithromycin | 1 | 2009 | 87 | 0.080 |
Why?
|
Mental Health Services | 1 | 2020 | 1729 | 0.080 |
Why?
|
Pneumonectomy | 1 | 2016 | 1147 | 0.080 |
Why?
|
Depression | 1 | 2008 | 8230 | 0.080 |
Why?
|
Feasibility Studies | 2 | 2025 | 5300 | 0.080 |
Why?
|
Immune Reconstitution Inflammatory Syndrome | 1 | 2008 | 61 | 0.080 |
Why?
|
Confidence Intervals | 2 | 2012 | 2915 | 0.070 |
Why?
|
Delivery of Health Care | 3 | 2012 | 5367 | 0.070 |
Why?
|
Public Health Administration | 2 | 2007 | 242 | 0.070 |
Why?
|
Age Distribution | 2 | 2004 | 2865 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12061 | 0.070 |
Why?
|
Survival Analysis | 2 | 2017 | 10087 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2014 | 4054 | 0.070 |
Why?
|
Microbiological Techniques | 1 | 2008 | 96 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3108 | 0.070 |
Why?
|
Siphonaptera | 1 | 2006 | 6 | 0.070 |
Why?
|
Ectoparasitic Infestations | 1 | 2006 | 12 | 0.070 |
Why?
|
Education, Medical, Continuing | 1 | 2012 | 829 | 0.070 |
Why?
|
Cost of Illness | 2 | 2023 | 1949 | 0.070 |
Why?
|
Treatment Failure | 3 | 2016 | 2653 | 0.060 |
Why?
|
Efficiency, Organizational | 1 | 2010 | 695 | 0.060 |
Why?
|
Infant, Newborn | 4 | 2018 | 26381 | 0.060 |
Why?
|
Urban Health | 1 | 2008 | 531 | 0.060 |
Why?
|
Superinfection | 1 | 2006 | 61 | 0.060 |
Why?
|
Peer Group | 1 | 2011 | 702 | 0.060 |
Why?
|
Medical Errors | 1 | 2014 | 1260 | 0.060 |
Why?
|
Information Systems | 1 | 2007 | 400 | 0.060 |
Why?
|
Professional Competence | 1 | 2008 | 429 | 0.060 |
Why?
|
Health Plan Implementation | 2 | 2007 | 337 | 0.060 |
Why?
|
Health Policy | 2 | 2022 | 2700 | 0.060 |
Why?
|
Substance-Related Disorders | 2 | 2020 | 4418 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3465 | 0.060 |
Why?
|
Drug Administration Schedule | 4 | 2016 | 4853 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6820 | 0.060 |
Why?
|
Comorbidity | 3 | 2023 | 10579 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14747 | 0.060 |
Why?
|
Treatment Refusal | 1 | 2008 | 433 | 0.060 |
Why?
|
Patients | 1 | 2011 | 908 | 0.060 |
Why?
|
Databases, Factual | 2 | 2017 | 8062 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6490 | 0.060 |
Why?
|
Capreomycin | 1 | 2004 | 14 | 0.060 |
Why?
|
Drug Resistance, Microbial | 2 | 2005 | 832 | 0.060 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2007 | 497 | 0.060 |
Why?
|
CD4 Lymphocyte Count | 1 | 2010 | 2586 | 0.060 |
Why?
|
Clinical Protocols | 3 | 2014 | 1437 | 0.060 |
Why?
|
Blood Glucose | 1 | 2018 | 6421 | 0.050 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 1988 | 0.050 |
Why?
|
Sex Factors | 1 | 2017 | 10614 | 0.050 |
Why?
|
Metabolism, Inborn Errors | 1 | 2005 | 291 | 0.050 |
Why?
|
Primary Prevention | 1 | 2010 | 1187 | 0.050 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2010 | 6020 | 0.050 |
Why?
|
Contact Tracing | 1 | 2005 | 274 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2016 | 39243 | 0.050 |
Why?
|
Ambulatory Care | 3 | 2008 | 2778 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2020 | 4863 | 0.050 |
Why?
|
Information Dissemination | 1 | 2010 | 1142 | 0.050 |
Why?
|
Self Care | 1 | 2007 | 800 | 0.050 |
Why?
|
Inservice Training | 1 | 2004 | 375 | 0.050 |
Why?
|
Lesotho | 1 | 2022 | 77 | 0.050 |
Why?
|
Regression Analysis | 1 | 2011 | 6324 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2009 | 1794 | 0.050 |
Why?
|
Incidence | 4 | 2023 | 21513 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2010 | 1218 | 0.050 |
Why?
|
Preventive Health Services | 1 | 2006 | 571 | 0.050 |
Why?
|
Insurance Benefits | 1 | 2023 | 186 | 0.050 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2007 | 1354 | 0.050 |
Why?
|
Odds Ratio | 2 | 2012 | 9657 | 0.050 |
Why?
|
Risk Assessment | 3 | 2017 | 24276 | 0.050 |
Why?
|
Atrial Flutter | 1 | 2023 | 253 | 0.050 |
Why?
|
Respiratory Insufficiency | 1 | 2010 | 1241 | 0.050 |
Why?
|
Mutation | 2 | 2005 | 30209 | 0.050 |
Why?
|
HIV-1 | 2 | 2009 | 6948 | 0.050 |
Why?
|
Interview, Psychological | 1 | 2004 | 811 | 0.050 |
Why?
|
Pelvic Bones | 1 | 2003 | 273 | 0.040 |
Why?
|
Age Factors | 1 | 2017 | 18386 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2012 | 3214 | 0.040 |
Why?
|
Magnesium | 1 | 2004 | 815 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2011 | 7843 | 0.040 |
Why?
|
Neonatal Screening | 1 | 2005 | 619 | 0.040 |
Why?
|
Family Characteristics | 1 | 2005 | 1001 | 0.040 |
Why?
|
Communication | 1 | 2014 | 3909 | 0.040 |
Why?
|
Video Recording | 1 | 2025 | 977 | 0.040 |
Why?
|
Cross Infection | 1 | 2008 | 1427 | 0.040 |
Why?
|
Food Preferences | 1 | 2022 | 397 | 0.040 |
Why?
|
Radiography | 1 | 2010 | 6943 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2014 | 4306 | 0.040 |
Why?
|
Cooperative Behavior | 2 | 2020 | 1512 | 0.040 |
Why?
|
Nutrition Policy | 1 | 2022 | 467 | 0.040 |
Why?
|
Medical Records | 1 | 2004 | 1408 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2012 | 5340 | 0.040 |
Why?
|
Survival Rate | 1 | 2012 | 12827 | 0.040 |
Why?
|
Secondary Prevention | 2 | 2016 | 1470 | 0.040 |
Why?
|
Drug Resistance, Bacterial | 1 | 2005 | 1065 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2008 | 15882 | 0.040 |
Why?
|
Self Efficacy | 1 | 2022 | 641 | 0.040 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 871 | 0.040 |
Why?
|
Capacity Building | 1 | 2020 | 266 | 0.040 |
Why?
|
Electromyography | 1 | 2003 | 1398 | 0.040 |
Why?
|
Decision Making | 1 | 2011 | 3955 | 0.040 |
Why?
|
Hospitalization | 1 | 2017 | 10811 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4249 | 0.040 |
Why?
|
Developed Countries | 1 | 2020 | 452 | 0.040 |
Why?
|
India | 1 | 2024 | 2334 | 0.030 |
Why?
|
Health Planning | 1 | 1998 | 233 | 0.030 |
Why?
|
Water | 1 | 2023 | 1416 | 0.030 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 499 | 0.030 |
Why?
|
Morals | 1 | 1998 | 288 | 0.030 |
Why?
|
Korea | 2 | 2005 | 97 | 0.030 |
Why?
|
Quality Control | 2 | 2008 | 835 | 0.030 |
Why?
|
Risk | 2 | 2016 | 9599 | 0.030 |
Why?
|
National Health Programs | 2 | 2010 | 444 | 0.030 |
Why?
|
Unsafe Sex | 1 | 2016 | 239 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 4780 | 0.030 |
Why?
|
Learning | 1 | 2022 | 1755 | 0.030 |
Why?
|
Diglycerides | 1 | 1993 | 174 | 0.030 |
Why?
|
World Health Organization | 1 | 1998 | 1326 | 0.020 |
Why?
|
Georgia (Republic) | 1 | 2011 | 39 | 0.020 |
Why?
|
Recurrence | 2 | 2016 | 8494 | 0.020 |
Why?
|
Tuberculin Test | 1 | 2012 | 205 | 0.020 |
Why?
|
Ceramides | 1 | 1993 | 202 | 0.020 |
Why?
|
Lung | 1 | 2010 | 10063 | 0.020 |
Why?
|
Protein-Energy Malnutrition | 1 | 2012 | 189 | 0.020 |
Why?
|
Endemic Diseases | 1 | 2012 | 190 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2012 | 570 | 0.020 |
Why?
|
Drug Therapy | 1 | 2014 | 504 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10737 | 0.020 |
Why?
|
Complement Activation | 1 | 1993 | 431 | 0.020 |
Why?
|
Retreatment | 1 | 2012 | 598 | 0.020 |
Why?
|
Risk-Taking | 1 | 2016 | 1021 | 0.020 |
Why?
|
Siberia | 1 | 2009 | 30 | 0.020 |
Why?
|
Stroke Volume | 1 | 2024 | 5595 | 0.020 |
Why?
|
Geographic Information Systems | 1 | 2012 | 281 | 0.020 |
Why?
|
Disease Outbreaks | 2 | 2012 | 1761 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 418 | 0.020 |
Why?
|
Hospitals, Chronic Disease | 1 | 2008 | 8 | 0.020 |
Why?
|
Disease Management | 1 | 1999 | 2531 | 0.020 |
Why?
|
Bacteriology | 1 | 2007 | 8 | 0.020 |
Why?
|
HIV Seronegativity | 1 | 2008 | 209 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2008 | 20700 | 0.020 |
Why?
|
Demography | 1 | 2012 | 1641 | 0.020 |
Why?
|
Internet | 2 | 2010 | 3107 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 1999 | 5531 | 0.020 |
Why?
|
Education | 1 | 2008 | 531 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6208 | 0.010 |
Why?
|
Rural Health | 1 | 2006 | 301 | 0.010 |
Why?
|
ROC Curve | 1 | 2012 | 3614 | 0.010 |
Why?
|
Haiti | 1 | 2006 | 553 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6544 | 0.010 |
Why?
|
Blood Specimen Collection | 1 | 2005 | 238 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8725 | 0.010 |
Why?
|
Leg Length Inequality | 1 | 2003 | 56 | 0.010 |
Why?
|
Sacroiliac Joint | 1 | 2003 | 58 | 0.010 |
Why?
|
Acidosis | 1 | 2005 | 271 | 0.010 |
Why?
|
Interdisciplinary Communication | 1 | 2008 | 931 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2009 | 2426 | 0.010 |
Why?
|
Diet | 1 | 2020 | 8087 | 0.010 |
Why?
|
Drug Tolerance | 1 | 2003 | 365 | 0.010 |
Why?
|
Prognosis | 2 | 2012 | 29912 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 2007 | 937 | 0.010 |
Why?
|
Community Health Centers | 1 | 2005 | 469 | 0.010 |
Why?
|
Stroke | 1 | 2023 | 9748 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36548 | 0.010 |
Why?
|
Animals | 3 | 2009 | 168800 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 2003 | 543 | 0.010 |
Why?
|
Algorithms | 2 | 2012 | 14066 | 0.010 |
Why?
|
Life Style | 1 | 2011 | 3928 | 0.010 |
Why?
|
China | 1 | 2005 | 2383 | 0.010 |
Why?
|
Amino Acids | 1 | 2005 | 1710 | 0.010 |
Why?
|
Quality Improvement | 1 | 2014 | 3849 | 0.010 |
Why?
|
Sampling Studies | 1 | 2000 | 613 | 0.010 |
Why?
|
Research Design | 1 | 2014 | 6206 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2005 | 2195 | 0.010 |
Why?
|
Fatty Acids | 1 | 2005 | 1805 | 0.010 |
Why?
|
Anti-Retroviral Agents | 1 | 2006 | 1786 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2009 | 3270 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2008 | 3617 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14645 | 0.010 |
Why?
|
Complement C9 | 1 | 1993 | 9 | 0.010 |
Why?
|
Virulence Factors, Bordetella | 1 | 1993 | 152 | 0.010 |
Why?
|
Pertussis Toxin | 1 | 1993 | 174 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2005 | 3830 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1993 | 858 | 0.010 |
Why?
|
Phosphatidylcholines | 1 | 1993 | 403 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 13028 | 0.010 |
Why?
|
Molecular Weight | 1 | 1993 | 2161 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1993 | 1751 | 0.000 |
Why?
|
Mental Disorders | 1 | 2008 | 6871 | 0.000 |
Why?
|
Protein Kinase C | 1 | 1993 | 1205 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2006 | 15808 | 0.000 |
Why?
|
Phosphorylation | 1 | 1993 | 8292 | 0.000 |
Why?
|
Mice | 1 | 1993 | 81839 | 0.000 |
Why?
|